HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 4.65
Day range
kr 4.56 - kr 4.89
Year range
kr 4.08 - kr 9.30
Market cap
1.60B SEK
Avg Volume
487.48K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 13.90M | 135.59% |
Operating expense | 86.10M | 1.41% |
Net income | -71.90M | 9.56% |
Net profit margin | -517.27 | 61.61% |
Earnings per share | -0.20 | 33.33% |
EBITDA | -74.40M | 6.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 192.60M | 7.48% |
Total assets | 646.60M | 6.21% |
Total liabilities | 245.10M | 323.32% |
Total equity | 401.50M | — |
Shares outstanding | 292.57M | — |
Price to book | 3.39 | — |
Return on assets | -27.96% | — |
Return on capital | -34.11% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -71.90M | 9.56% |
Cash from operations | -56.40M | 12.15% |
Cash from investing | — | — |
Cash from financing | -600.00K | 0.00% |
Net change in cash | -59.20M | 7.93% |
Free cash flow | -26.55M | 20.00% |
About
Founded
2006
Website
Employees
34